Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide

PURPOSE: The phase 3 CHIASMA OPTIMAL trial (NCT03252353) evaluated efficacy and safety of oral octreotide capsules (OOCs) in patients with acromegaly who previously demonstrated biochemical control while receiving injectable somatostatin receptor ligands (SRLs). METHODS: In this double-blind study,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Endocrinol Metab
Auteurs principaux: Samson, Susan L, Nachtigall, Lisa B, Fleseriu, Maria, Gordon, Murray B, Bolanowski, Marek, Labadzhyan, Artak, Ur, Ehud, Molitch, Mark, Ludlam, William H, Patou, Gary, Haviv, Asi, Biermasz, Nienke, Giustina, Andrea, Trainer, Peter J, Strasburger, Christian J, Kennedy, Laurence, Melmed, Shlomo
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2020
Sujets:
Online Only Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470473/
https://ncbi.nlm.nih.gov/pubmed/32882036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgaa526
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires